Tags SignatureCLL

Tag: SignatureCLL News

SignatuRx Test Shown to Reduce Early Cancer Deaths is Now Available to CLL Patients

HUNTINGTON BEACH, Calif. /California Newswire/ -- SignatureCLL today announced that the first laboratory test ever shown in a clinical trial to improve one year survival rates in cancer is now available to patients with chronic lymphocytic leukemia (CLL). The U.S. cancer physician who invented the test and the British scientist who used it to make discoveries in leukemia will offer the test under the trade name SignatuRx through their own, newly-formed laboratory company.